These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 1281074)

  • 41. A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
    Malaviya AN; Kapoor S; Garg S; Ahmad I; Raja RR
    J Assoc Physicians India; 2007 Mar; 55():193-7. PubMed ID: 17598330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
    Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
    Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis.
    Benitez-Del-Castillo JM; Garcia-Sanchez J; Iradier T; Bañares A
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():340-3. PubMed ID: 11026996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [NSAIDs and COX-2-inhibitors: current status].
    Kneitz C; Tony HP; Krüger K
    Internist (Berl); 2006 May; 47(5):533-4, 536-8, 540. PubMed ID: 16557412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coxibs: a significant therapeutic opportunity.
    Gatti D; Adami S
    Acta Biomed; 2010 Dec; 81(3):217-24. PubMed ID: 22530460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimisation of antirheumatic drug treatment in pregnancy.
    Ostesen M
    Clin Pharmacokinet; 1994 Dec; 27(6):486-503. PubMed ID: 7882637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.
    Johnson AG; Seideman P; Day RO
    Drug Saf; 1993 Feb; 8(2):99-127. PubMed ID: 8452660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Maksymowych WP; Jhangri GS; Fitzgerald AA; LeClercq S; Chiu P; Yan A; Skeith KJ; Aaron SL; Homik J; Davis P; Sholter D; Russell AS
    Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of anti-inflammatory analgesics in sickle-cell disease.
    Han J; Saraf SL; Lash JP; Gordeuk VR
    J Clin Pharm Ther; 2017 Oct; 42(5):656-660. PubMed ID: 28695614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proquazone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases and pain states.
    Clissold SP; Beresford R
    Drugs; 1987 May; 33(5):478-502. PubMed ID: 3297621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.
    De Keyser F; Baeten D; Van den Bosch F; Kruithof E; Verbruggen G; Mielants H; Veys E
    Drugs; 2004; 64(24):2793-811. PubMed ID: 15563249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coexisting ankylosing spondylitis and Sjogren's syndrome: a case report.
    Tosun M; Karkucak M; Capkin E; Cakirbay H; Guler M; Topbas M
    Rheumatol Int; 2005 Aug; 25(6):478-80. PubMed ID: 15761725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions.
    Balfour JA; Fitton A; Barradell LB
    Drugs; 1996 Apr; 51(4):639-57. PubMed ID: 8706598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical study on treatment of patients with ankylosing spondylitis by Panlongqi tablet].
    Zhao FT; Zhao H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jun; 27(6):540-2. PubMed ID: 17633369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic advances in ankylosing spondylitis.
    Toussirot E; Wendling D
    Expert Opin Investig Drugs; 2001 Jan; 10(1):21-9. PubMed ID: 11116278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological management of back pain syndromes.
    Porter RW; Ralston SH
    Drugs; 1994 Aug; 48(2):189-98. PubMed ID: 7527324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonsteroidal anti-inflammatory drugs for postoperative pain: a focus on children.
    Kokki H
    Paediatr Drugs; 2003; 5(2):103-23. PubMed ID: 12529163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
    Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.
    Jafarnezhad-Ansariha F; Yekaninejad MS; Jamshidi AR; Mansouri R; Vojdanian M; Mahmoudi M; Fattahi MJ; Hashemi SN; Rehm BHA; Matsuo H; Esposito E; Cuzzocrea S; Mirshafiey A
    Inflammopharmacology; 2018 Apr; 26(2):375-384. PubMed ID: 28819782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.